Portfolio (Quarterly)
Guide ↗
Velan Capital Investment Management LP
· CIK 0001848809| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | LYEL | LYELL IMMUNOPHARMA INC | Healthcare | 102,000.0 | $2.0M | 1.28% | NEW | — | $20.06 | -33.2% |
| 22 | PROF | PROFOUND MED CORP | Healthcare | 285,710.0 | $1.9M | 1.16% | — | — | $6.48 | +9.6% |
| 23 | VRDN | VIRIDIAN THERAPEUTICS INC | Healthcare | 91,123.0 | $1.8M | 1.12% | +5K | +5.3% | $19.56 | -2.5% |
| 24 | RCKT | ROCKET PHARMACEUTICALS INC | Healthcare | 294,643.0 | $1.1M | 0.66% | NEW | — | $3.58 | +1.7% |
| 25 | KZIA | KAZIA THERAPEUTICS LTD | Healthcare | 135,315.0 | $1.0M | 0.63% | -165K | -54.9% | $7.44 | +81.0% |
| 26 | — | NASUS PHARMA LTD | — | 359,390.0 | $798K | 0.50% | NEW | — | $2.22 | — |
| 27 | QNRX | QUOIN PHARMACEUTICALS LTD | Healthcare | 84,849.0 | $560K | 0.35% | NEW | — | $6.60 | -34.1% |
| 28 | ARWR | ARROWHEAD PHARMACEUTICALS IN | Healthcare | 6,500.0 | $408K | 0.26% | — | — | $62.70 | +14.7% |
| 29 | PTGX | PROTAGONIST THERAPEUTICS INC | Healthcare | 3,700.0 | $390K | 0.24% | — | — | $105.40 | +24.5% |
| 30 | OVID | OVID THERAPEUTICS INC | Healthcare | 160,000.0 | $355K | 0.22% | — | — | $2.22 | +10.8% |
| 31 | MLYS | MINERALYS THERAPEUTICS INC | Healthcare | 11,000.0 | $298K | 0.19% | -140K | -92.7% | $27.09 | +0.7% |
| 32 | CNTX | CONTEXT THERAPEUTICS INC | Healthcare | 100,000.0 | $262K | 0.16% | — | — | $2.62 | -76.2% |
| 33 | NRIX | NURIX THERAPEUTICS INC | Healthcare | 16,000.0 | $248K | 0.15% | — | — | $15.50 | +48.3% |
| 34 | — | CORBUS PHARMACEUTICALS HLDGS | — | 26,000.0 | $244K | 0.15% | +13K | +100.0% | $9.39 | — |
| 35 | SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | 10,000.0 | $234K | 0.15% | -120K | -92.3% | $23.36 | +3.3% |
| 36 | — | PRECISION BIOSCIENCES INC | — | 40,000.0 | $220K | 0.14% | +20K | +100.0% | $5.50 | — |
| 37 | IMNM | IMMUNOME INC | Healthcare | 10,000.0 | $219K | 0.14% | — | — | $21.87 | +3.3% |
| 38 | DSGN | DESIGN THERAPEUTICS INC | Healthcare | 20,000.0 | $213K | 0.13% | — | — | $10.64 | +28.5% |
| 39 | — | ARTIVA BIOTHERAPEUTICS INC | — | 25,000.0 | $161K | 0.10% | NEW | — | $6.44 | — |
| 40 | NMRA | NEUMORA THERAPEUTICS INC. | Healthcare | 80,000.0 | $156K | 0.10% | NEW | — | $1.95 | -19.0% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%